Telling the truth: why disclosure matters in chronic kidney disease.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

12 citing papers in PubMed.

1. Effect of information and telephone-guided access to community support for people with chronic kidney disease: randomised controlled trial.PloS one · 2014
   Trial
2. The clinical and cost-effectiveness of the BRinging Information and Guided Help Together (BRIGHT) intervention for the self-management support of people with stage 3 chronic kidney disease in primary care: study protocol for a randomized controlled trial.Trials · 2013
   Trial
3. Chronic Kidney Disease Guideline Implementation in Primary Care: A Qualitative Report from the TRANSLATE CKD Study.Journal of the American Board of Family Medicine : JABFM
   Trial
4. Chronic kidney disease and the alternative labels used by GPs in Australia: a qualitative interview study.BJGP open · 2025
   Article
5. Chronic kidney disease: detect, diagnose, disclose-a UK primary care perspective of barriers and enablers to effective kidney care.BMC medicine · 2024
   Review
6. Monitoring and management of chronic kidney disease in ambulatory care - analysis of clinical and claims data from a population-based study.BMC health services research · 2022
   Article
7. CKD Awareness Among US Adults by Future Risk of Kidney Failure.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2020
   Article
8. What drives quality improvement in chronic kidney disease (CKD) in primary care: process evaluation of the Quality Improvement in Chronic Kidney Disease (QICKD) trial.BMJ open · 2016
   Article
9. Predictors of patient self-report of chronic kidney disease: baseline analysis of a randomised controlled trial.BMC family practice · 2014
   Article
10. A quality improvement project to improve the effectiveness and patient-centredness of management of people with mild-to-moderate kidney disease in primary care.BMJ quality improvement reports · 2014
    Article
11. Telling the truth: why disclosure matters in chronic kidney disease.The British journal of general practice : the journal of the Royal College of General Practitioners · 2012
    Article
12. Telling the truth: why disclosure matters in chronic kidney disease.The British journal of general practice : the journal of the Royal College of General Practitioners · 2012
    Article

Corrections and comments

• Commented on by
  Telling the truth: why disclosure matters in chronic kidney disease.2012
• Commented on by
  Telling the truth: why disclosure matters in chronic kidney disease.2012
• Comment on
  Treatment needs and diagnosis awareness in primary care patients with chronic kidney disease.2012
• Comment on
  Understanding the management of early-stage chronic kidney disease in primary care: a qualitative study.2012

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as